Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Interest Expenses (2016 - 2025)

Nutex Health's Interest Expenses history spans 13 years, with the latest figure at $5.0 million for Q4 2025.

  • For Q4 2025, Interest Expenses fell 1.5% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $22.2 million, up 11.51%, while the annual FY2025 figure was $22.2 million, 11.51% up from the prior year.
  • Interest Expenses for Q4 2025 was $5.0 million at Nutex Health, down from $5.5 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $6.1 million in Q1 2025 and bottomed at $334331.0 in Q1 2021.
  • The 5-year median for Interest Expenses is $4.3 million (2022), against an average of $3.8 million.
  • The largest YoY upside for Interest Expenses was 6804.38% in 2021 against a maximum downside of 62.74% in 2021.
  • A 5-year view of Interest Expenses shows it stood at $2.3 million in 2021, then grew by 25.93% to $2.9 million in 2022, then soared by 48.02% to $4.2 million in 2023, then increased by 19.25% to $5.1 million in 2024, then fell by 1.5% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Interest Expenses are $5.0 million (Q4 2025), $5.5 million (Q3 2025), and $5.7 million (Q2 2025).